On Friday, Verrica Pharmaceuticals Inc (NASDAQ: VRCA) opened higher 13.02% from the last session, before settling in for the closing price of $0.65. Price fluctuations for VRCA have ranged from $0.61 to $11.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -17.00% over the last five years. Company’s average yearly earnings per share was noted 2.30% at the time writing. With a float of $49.03 million, this company’s outstanding shares have now reached $90.56 million.
The firm has a total of 100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 72.9%, operating margin of -815.5%, and the pretax margin is -922.81%.
Verrica Pharmaceuticals Inc (VRCA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Verrica Pharmaceuticals Inc is 45.86%, while institutional ownership is 33.10%. The most recent insider transaction that took place on Aug 26 ’24, was worth 69,647. In this transaction CHIEF LEGAL OFFICER of this company sold 26,183 shares at a rate of $2.66, taking the stock ownership to the 115,303 shares. Before that another transaction happened on Aug 27 ’24, when Company’s CHIEF LEGAL OFFICER sold 9,530 for $2.46, making the entire transaction worth $23,444. This insider now owns 105,773 shares in total.
Verrica Pharmaceuticals Inc (VRCA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.86% during the next five years compared to -0.97% drop over the previous five years of trading.
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) Trading Performance Indicators
Check out the current performance indicators for Verrica Pharmaceuticals Inc (VRCA). In the past quarter, the stock posted a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.83, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Verrica Pharmaceuticals Inc (VRCA)
Analysing the last 5-days average volume posted by the [Verrica Pharmaceuticals Inc, VRCA], we can find that recorded value of 0.22 million was lower than the volume posted last year of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 50.40%. Additionally, its Average True Range was 0.06.
During the past 100 days, Verrica Pharmaceuticals Inc’s (VRCA) raw stochastic average was set at 10.41%, which indicates a significant decrease from 85.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.40% in the past 14 days, which was lower than the 141.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7364, while its 200-day Moving Average is $3.6038. Now, the first resistance to watch is $0.7778. This is followed by the second major resistance level at $0.8189. The third major resistance level sits at $0.8810. If the price goes on to break the first support level at $0.6746, it is likely to go to the next support level at $0.6125. Should the price break the second support level, the third support level stands at $0.5714.
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) Key Stats
There are currently 45,601K shares outstanding in the company with a market cap of 66.72 million. Presently, the company’s annual sales total 5,120 K according to its annual income of -67,000 K. Last quarter, the company’s sales amounted to 5,180 K and its income totaled -17,190 K.
